| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_11172025_BBLG_Sorensen.pdf
One-Year OutlookThe firm expect to achieve a number of value-creating events in the coming year under our cost-efficient busine...
Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(1.33) per share which missed the analyst consensus estimate of $(0....